About us
Yue Shen, PhD
Senior Vice President of Medicine
15 years of experience in R&D and Regulatory affairs. Served as Manager of Global Regulatory Affairs at Novartis Vaccines & Diagnostics, received 20+ IVD and medical device approvals in APAC and North America
Managed Global Regulatory Affairs at Betta Pharmaceuticals and then established Betta’s Early Clinical Development Team. Led 10+ first in human studies and clinical pharmacology studies, of which ensartinib (ALKi) has been approved in China since 2020
Currently leading clinical team to conduct clinical development of LP-108, LP-118 and LP-168